Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
25.70
-0.15 (-0.58%)
At close: Mar 9, 2026
SHE:300204 Market Cap
SHE:300204 has a market cap or net worth of 12.28 billion as of March 9, 2026. Its market cap has increased by 256.45% in one year.
Market Cap
12.28B
Enterprise Value
12.15B
Revenue
244.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.70
Market Cap Chart
Since April 15, 2011, SHE:300204's market cap has increased from 3.33B to 12.28B, an increase of 269.03%. That is a compound annual growth rate of 9.16%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InventisBio | 12.37B |
| Vcanbio Cell & Gene Engineering Corp., | 12.81B |
| Beijing Hotgen Biotech | 11.90B |
| Chengdu Olymvax Biopharmaceuticals | 11.88B |
| Mabwell (Shanghai) Bioscience | 12.89B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 13.01B |
| Hualan Biological Vaccine | 11.55B |
| Pacific Shuanglin Bio-pharmacy | 13.33B |